June 1, 2023

U.S. Reps. Gus Bilirakis (R-FL), Tony Cardenas (D-CA), Greg Murphy, MD (R-NC), and Danny Davis (D-IL) introduced the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) May 27.

Clinical labor staff, medical supplies and equipment costs are three components of direct practice expense (PE) inputs, costs directly associated with the provision of a service or procedure. They are budget neutral, which means that an increase in payment for one component typically means a proportional code-level decrease in payment in the other components.

If enacted, the legislation would mitigate significant code-level cuts resulting from a recent clinical labor update by providing an increase to non-facility PE relative value units for those procedures performed in an office-based setting that utilize high-tech medical devices and/or equipment.

The American College of Radiology® (ACR®) joins the Society for Interventional Radiology, the American Society for Radiation Oncology and many others in supporting this legislation and looks forward to working to ensure final passage.

For more information, contact Rebecca Spangler, ACR Senior Government Relations Director.


Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more